scholarly journals Serum endothelin 1 and interleukin 8 are elevated in patients with active wet age‐related macular degeneration without a clear serological link to epithelial‐mesenchymal transition: a Finnish cohort

2022 ◽  
Vol 100 (S267) ◽  
Author(s):  
Mikko Liukkonen ◽  
Jussi Paterno ◽  
Ali Koskela ◽  
Kai Kaarniranta
Biomedicines ◽  
2020 ◽  
Vol 8 (6) ◽  
pp. 147 ◽  
Author(s):  
Madhu Sudhana Saddala ◽  
Anton Lennikov ◽  
Anthony Mukwaya ◽  
Hu Huang

Age-related macular degeneration (AMD) is the most common cause of irreversible blindness in the elderly population. In our previous studies, we found that deficiency of CXCR5 causes AMD-like pathological phenotypes in mice, characterized by abnormalities and dysfunction of the retinal pigment epithelium (RPE) cells. The abnormalities included abnormal cellular shape and impaired barrier function. In the present study, primary RPE cells were derived separately from CXCR5 knockout (KO) mice and from C57BL6 wild type (WT). The isolated primary cells were cultured for several days, and then total RNA was isolated and used for library preparation, sequencing, and the resultant raw data analyzed. Relative to the WT, a total of 1392 differentially expressed genes (DEG) were identified. Gene ontology analysis showed various biological processes, cellular components, and molecular functions were enriched. Pathway enrichment analysis revealed several pathways, including the PI3K-Akt signaling, mTOR signaling, FoxO, focal adhesion, endocytosis, ubiquitin-mediated proteolysis, TNFα-NF-kB Signaling, adipogenesis genes, p53 signaling, Ras, autophagy, epithelial–mesenchymal transition (EMT), and mitochondrial pathway. This study explores molecular signatures associated with deficiency of CXCR5 in RPE cells. Many of these signatures are important for homeostasis of this tissue. The identified pathways and genes require further evaluation to better understand the pathophysiology of AMD.


2008 ◽  
Vol 9 (1) ◽  
pp. 118
Author(s):  
A. Ghorbanihaghjo ◽  
A. Javadzadeh ◽  
N. Rashtchizadeh ◽  
M. Rohbaninoubar ◽  
S. Masoodnia ◽  
...  

2008 ◽  
Vol 92 (4) ◽  
pp. 537-540 ◽  
Author(s):  
S V Goverdhan ◽  
S Ennis ◽  
S R Hannan ◽  
K C Madhusudhana ◽  
A J Cree ◽  
...  

2015 ◽  
Vol 93 (8) ◽  
pp. 726-733 ◽  
Author(s):  
Asta Hautamäki ◽  
Sanna Seitsonen ◽  
Juha M. Holopainen ◽  
Jukka A. Moilanen ◽  
Jarno Kivioja ◽  
...  

2020 ◽  
Vol 21 (12) ◽  
pp. 4271 ◽  
Author(s):  
Daisy Y. Shu ◽  
Erik Butcher ◽  
Magali Saint-Geniez

Epithelial–mesenchymal transition (EMT) and endothelial–mesenchymal transition (EndMT) are physiological processes required for normal embryogenesis. However, these processes can be hijacked in pathological conditions to facilitate tissue fibrosis and cancer metastasis. In the eye, EMT and EndMT play key roles in the pathogenesis of subretinal fibrosis, the end-stage of age-related macular degeneration (AMD) that leads to profound and permanent vision loss. Predominant in subretinal fibrotic lesions are matrix-producing mesenchymal cells believed to originate from the retinal pigment epithelium (RPE) and/or choroidal endothelial cells (CECs) through EMT and EndMT, respectively. Recent evidence suggests that EMT of RPE may also be implicated during the early stages of AMD. Transforming growth factor-beta (TGFβ) is a key cytokine orchestrating both EMT and EndMT. Investigations in the molecular mechanisms underpinning EMT and EndMT in AMD have implicated a myriad of contributing factors including signaling pathways, extracellular matrix remodelling, oxidative stress, inflammation, autophagy, metabolism and mitochondrial dysfunction. Questions arise as to differences in the mesenchymal cells derived from these two processes and their distinct mechanistic contributions to the pathogenesis of AMD. Detailed discussion on the AMD microenvironment highlights the synergistic interactions between RPE and CECs that may augment the EMT and EndMT processes in vivo. Understanding the differential regulatory networks of EMT and EndMT and their contributions to both the dry and wet forms of AMD can aid the development of therapeutic strategies targeting both RPE and CECs to potentially reverse the aberrant cellular transdifferentiation processes, regenerate the retina and thus restore vision.


2010 ◽  
Vol 7 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Amir Ghorbanihaghjo ◽  
Alireza Javadzadeh ◽  
Nadereh Rashtchizadeh ◽  
Hassan Argani ◽  
Sima Masoodnia ◽  
...  

Retina ◽  
2013 ◽  
Vol 33 (9) ◽  
pp. 1815-1827 ◽  
Author(s):  
Asta Hautamäki ◽  
Jarno Kivioja ◽  
Satu Vavuli ◽  
Sakari Kakko ◽  
Eeva-Riitta Savolainen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document